Glenmark Pharmaceuticals gets approvals from USFDA for generic Prograf capsules
Glenmark Pharmaceuticals Inc., USA has received final approval by the United States Food & Drug Administration (USFDA) for Tacrolimus Capsules USP, 0.5 mg, 1...
Godrej partners with India’s universal immunisation programme
Godrej Appliances will be commissioning vaccine refrigerators and deep freezers under the pan India programme by Ministry of Health & Family Welfare.
It has commissioned...
Biocon Biologics gets $150 mn capital dose from Goldman Sachs
The Board of Biocon Biologics Ltd has approved a Rs 1,125 Crore (~USD 150 million) capital injection from Goldman Sachs.
Biocon Biologics is a subsidiary...
Bausch starts study for dry eye disease linked with Meibomian Gland Dysfunction
Bausch Health Companies Inc and its global eye health business Bausch + Lomb have announced that the second of two Phase 3 studies evaluating...
Kinetic unveils UVC light-based sanitiser that kills 99.9% of coronavirus in 15 minutes
Kinetic Communications Ltd; a member of the Kinetic Group, has introduced 'UV WARRIOR', a portable disinfector that 'sanitises all daily objects and any room...
Covid breakthrough: Baricitinib plus remdesivir show promising results in treating Corona infection
Covid treatment is no more a dream. In a relif to those who are waiting for Covid-19 medicine, it has emerged that combination of...
Sandoz ships first medicine in partnership with Civica Rx to United States hospitals
Sandoz Inc said it has pantoprazole sodium for injection, 40 mg to Civica Rx to supply hospitals in the United States it serves. This...
Persavita to test its natural health product in Covid-19
Persavita is gearing up for a clinical trial to test its experimental natural health product in Covid-19.
The company is gearing up to test this...
Lilly’s Bamlanivimab to be used as Covid-19 treatment
Bamlanivimab (LY-CoV555), a neutralising antibody emerged from collaboration between Lilly and Vancouver-based AbCellera, has been given authorisation by Health Canada, under the Interim Order...
Biohaven gives important update on phase 2/3 trial and Alzheimer’s disease program
Biohaven Pharmaceutical Holding Company Ltd has announced completed a focused analysis of the topline co-primary and key secondary data from its Phase 2/3 clinical...